Persistent Systems · Material risks, their source context, and severity in the latest available quarter.
ConCallIQ research layer
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
Management acknowledged the healthcare sector has been impacted by decisions under the new US administration, particularly affecting scientific instruments, medical devices, and research-oriented customers with grants. While pipeline remains good, execution risk exists as customers optimize costs in response to funding pressures.
Merit increments effective October 1, 2025 will impact Q3 margins by 180 basis points, with only 80-100 basis points expected to be offset through offshoring, utilization management, subcontractor rationalization, SG&A optimization, and ESOP cost reduction. This leaves a net ~80-100bps margin headwind for Q3.
Software license costs surged to ~6-7% of revenue from historical ~2.5-3% due to a large multi-year customer commitment that is now ending. Management noted the industry shift toward 'service as software' bundling makes future normalization unclear—rates could stay at 6% or increase further depending on AI transformation deal structures.
An analyst raised concern about potential pricing deflation as clients demand productivity benefits from AI implementations. Management responded that the issue is 'scope inflation/deflation' rather than per-unit pricing pressure, and noted billing rates are 'fairly consistently moving up.' However, the AI monetization model remains nascent.
